Se, että kaikki näyttää erilaiselta, ei tarkoita sitä, että kaikki olisi muuttunut…
Hakulomake
Etsi
English
Suomi
Deutsch
Magyar
Home
Science
Leisure
Languages
Literature
Running
Tech notes
Downloads
Email
My other sites
Olet täällä
Etusivu
» Biblio
Biblio
Export 7 results:
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Tekijä
[
Otsikko
]
Tyyppi
Vuosi
Suodattimet:
Tekijä
is
Holopainen, Tanja
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Bry M
,
Kivelä R
,
Holopainen T
,
Anisimov A
,
Tammela T
,
Soronen J
, ym.
.
Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation
. Circulation [Internet]. 2010;122(17):1725 - 33.
http://view.ncbi.nlm.nih.gov/pubmed/20937974
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Maija Bry et al., Circulation 2010
(2.23 MB)
Maija Bry et al., Circulation 2010, supplement
(17.77 MB)
He Y
,
Rajantie I
,
Pajusola K
,
Jeltsch M
,
Holopainen T
,
Yla-Herttuala S
, ym.
.
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
. Cancer Res [Internet]. 2005;65(11):4739 - 46.
http://view.ncbi.nlm.nih.gov/pubmed/15930292
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Yulong He et al., Cancer Research 2005
(1.82 MB)
T
Heckman CA
,
Holopainen T
,
Wirzenius M
,
Keskitalo S
,
Jeltsch M
,
Ylä-Herttuala S
, ym.
.
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
. Cancer Res [Internet]. 2008;68(12):4754 - 62.
http://view.ncbi.nlm.nih.gov/pubmed/18559522
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Caroline Heckman et al., Cancer Research 2008
(504.8 KB)
I
Inhibiton of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171
. Teoksessa 98th Annual Meeting of the American-Association-for-Cancer-Research [Internet]. Los Angeles, CA: American Association for Cancer Research; 2007.
http://dx.doi.org/10.1158/0008-5472.CAN-07-5809
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf
(236.37 KB)
E
Tvorogov D
,
Anisimov A
,
Zheng W
,
Leppänen V-M
,
Tammela T
,
Laurinavicius S
, ym.
.
Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization
. Cancer Cell [Internet]. 2010;18(6):630 - 40.
http://view.ncbi.nlm.nih.gov/pubmed/21130043
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Denis Tvorogov et al., Cancer Cell 2010
(1.3 MB)
Denis Tvorogov et al., Cancer Cell 2010, supplement
(828.69 KB)
C
CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation
. Circulation [Internet]. 2014;129(19).
http://circ.ahajournals.org/content/early/2014/02/19/CIRCULATIONAHA.113.002779.abstract
DOI
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation
(6.6 MB)
Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.)
(2.38 MB)
Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.)
(23.21 MB)
B
The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands
. Sci Signal. 2013;6(282):ra52.
PubMed
DOI
Google Scholar
BibTeX
RTF
Merkitty
MARC
EndNote XML
RIS
Anisimov 2013 Science Signaling
(1.92 MB)
Anisimov 2013 Science Signaling Supplement
(2.09 MB)